Randomized Double Blind Placebo Controlled Trial of Barrett's Esophagus Chemoprevention With Metformin.
Phase of Trial: Phase II
Latest Information Update: 06 May 2014
At a glance
- Drugs Metformin (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 11 Apr 2013 Planned end date changed from 1 Jun 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 11 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 25 Mar 2012 New source identified and integrated (Mayo Clinic).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History